EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)

PROVIDENCE, R.I., Feb. 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") today announces its participation in the INDIGO consortium - a partnership of public and private research and development organizations from the EU, India, and United States...
Canali: Ricerca Medica
News / di

Autore dell'articolo: Staff